Please login to the form below

Not currently logged in
Email:
Password:

New EMG leadership announced

The European Medicines Group has elected Matthew Speers as chair and Steve Turley as vice chair

Matthew Speers has been elected chair of the European Medicines Group (EMG), which represents the UK voice of research-driven pharmaceutical companies headquartered in continental Europe.

Speers is managing director of UCB UK and Ireland, a position he has held since March 2008. In his new capacity as chair, Speers will be supported by Steve Turley, managing director, Lundbeck, who was elected vice chair.

Commenting on his appointment, Speers said: "Despite the tremendous advances in research and development we continue to face considerable market access challenges in the UK with uptake of innovative medicines still lagging significantly behind Europe.

"I am delighted to have been elected to lead the EMG and to continue the work we have undertaken to ensure that all UK citizens have timely access to appropriate, innovative medicines taking other countries in Europe as our benchmark."

Speers succeeds Nigel Brooksby (sanofi-aventis) who led the group for two years.

25th August 2010

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
JPA Health

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
Rare thoughts & outcomes - navigating pathways to better outcomes in rare
...
How to pick the perfect training program for your healthcare professionals
You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...